Real world study on the efficacy and tolerability of ixabepilone monotherapy vs. combination therapy with capecitabine in metastatic breast cancer patients (MBC)

被引：0
|
作者：
Hyder, Tara [1 ]
Rosenzweig, Margaret [1 ]
Brufsky, Adam M. [1 ]
机构：
[1] Magee Womens Hosp, Pittsburgh, PA USA
来源：
CANCER RESEARCH | 2021年 / 81卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PS13-47
引用
收藏
页数：1
相关论文
共 50 条
  • [31] A randomized double-blind phase II study of the combination of oral WX-671 plus capecitabine vs. capecitabine monotherapy in first-line HER2-negative metastatic breast cancer (MBC)
    Goldstein, L. J.
    Oliveria, C. T.
    Heinrich, B.
    Stemmer, S. M.
    Mala, C.
    Selder, S.
    Bevan, P.
    Harbeck, N.
    CANCER RESEARCH, 2012, 72
  • [32] Effect of age on tolerability and efficacy of eribulin and capecitabine in patients with metastatic breast cancer treated in study 301
    Kaufman, P. A.
    Yelle, L.
    Cortes, J.
    Perez, E. A.
    Awada, A.
    Wanders, J.
    Olivo, M. S.
    Dutcus, C. E.
    Twelves, C.
    CANCER RESEARCH, 2013, 73
  • [33] A Phase I Study of Ixabepilone in Combination With Epirubicin in Patients With Metastatic Breast Cancer
    Roche, Henri
    De Benedictis, Elena
    Cottura, Ewa
    Govi, Silvia
    Dalenc, Florence
    Locatelli, Alberta
    Deslandres, Marion
    Zambetti, Milvia
    Gladieff, Laurence
    Messina, Marianne
    Gianni, Luca
    CLINICAL BREAST CANCER, 2012, 12 (03) : 167 - 174
  • [34] Phase I study of ixabepilone in combination with capecitabine in Japanese patients with metastatic breast cancer previously treated with an anthracycline and a taxane.
    Watanabe, J.
    Horiguchi, J.
    Masuda, N.
    Aogi, K.
    Sato, R.
    Tokudome, T.
    Peck, R. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [35] A pooled analysis of efficacy and safety of vinorelbine in combination with capecitabine in first-line metastatic breast cancer (MBC)
    Valev, Spartak S.
    Taushanova, Margarita
    Krasteva, Ely
    ANNALS OF ONCOLOGY, 2007, 18 : 163 - 163
  • [36] Phase III study of ixabepilone plus capecitabine in patients with metastatic breast cancer (MBC) progressing after anthracyclines and taxanes:: subgroup analysis of patients receiving ixabepilone in the first-line setting
    Jassem, J.
    Thomas, E.
    Gomez, H.
    Li, R. K.
    Chung, H. C.
    Fein, L. E.
    Chan, V. F.
    Peck, R. A.
    Mukhopadhyay, P.
    Roche, H.
    EJC SUPPLEMENTS, 2007, 5 (04): : 213 - 214
  • [37] Capecitabine monotherapy for elderly patients with metastatic breast cancer.
    Minea, LN
    Stanculeanu, DL
    Cringeanu, A
    Anghel, RM
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 76S - 76S
  • [38] Capecitabine maintenance therapy after docetaxel/capecitabine combination chemotherapy in patients with metastatic breast cancer
    Gursoy, Pinar
    Surmeli, Zeki Gokhan
    Cakar, Burcu
    Arslan, Cagatay
    Zengel, Baha
    Karaca, Burcak
    Sezgin, Canfeza
    Karabulut, Bulent
    Sanli, Ulus Ali
    Uslu, Ruchan
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [39] Phase III trial of ixabepilone plus capecitabine compared to capecitabine alone in patients with metastatic breast cancer (MBC) previously treated or resistant to an anthracycline and resistant to taxanes
    Vahdat, L. T.
    Thomas, E.
    Li, R.
    Jassem, J.
    Gomez, H.
    Chung, H.
    Peck, R.
    Mukhopadhyay, P.
    Klimovsky, J.
    Roche, H.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [40] Efficacy of lapatinib combined with capecitabine in patients with HER2-positive metastatic breast cancer in a real-world study
    Gui, Xinyu
    Li, Huiping
    Yan, Ying
    Zhang, Ruyan
    ONCOLOGY LETTERS, 2020, 20 (06)
12345